Literature DB >> 23554291

Commonality in Down and fetal alcohol syndromes.

Jeffrey P Solzak1, Yun Liang, Feng C Zhou, Randall J Roper.   

Abstract

BACKGROUND: Down syndrome (DS) and Fetal Alcohol Syndrome (FAS) are two leading causes of birth defects with phenotypes ranging from craniofacial abnormalities to cognitive impairment. Despite different origins, we report that in addition to sharing many phenotypes, DS and FAS may have common underlying mechanisms of development.
METHODS: Literature was surveyed for DS and FAS as well as mouse models. Gene expression and apoptosis were compared in embryonic mouse models of DS and FAS by qPCR, immunohistochemical and immunoflurorescence analyses. The craniometry was examined using MicroCT at postnatal day 21.
RESULTS: A literature survey revealed over 20 comparable craniofacial and structural deficits in both humans with DS and FAS and corresponding mouse models. Similar phenotypes were experimentally found in pre- and postnatal craniofacial and neurological tissues of DS and FAS mice. Dysregulation of two genes, Dyrk1a and Rcan1, key to craniofacial and neurological precursors of DS, was shared in craniofacial precursors of DS and FAS embryos. Increased cleaved caspase 3 expression was also discovered in comparable regions of the craniofacial and brain precursors of DS and FAS embryos. Further mechanistic studies suggested overexpression of trisomic Ttc3 in DS embyros may influence nuclear pAkt localization and cell survival.
CONCLUSIONS: This first and initial study indicates that DS and FAS share common dysmorphologies in humans and animal models. This work also suggests common mechanisms at cellular and molecular levels that are disrupted by trisomy or alcohol consumption during pregnancy and lead to craniofacial and neurological phenotypes associated with DS or FAS.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23554291      PMCID: PMC4096968          DOI: 10.1002/bdra.23129

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  110 in total

1.  Embryonic and not maternal trisomy causes developmental attenuation in the Ts65Dn mouse model for Down syndrome.

Authors:  Joshua D Blazek; Cherie N Billingsley; Abby Newbauer; Randall J Roper
Journal:  Dev Dyn       Date:  2010-06       Impact factor: 3.780

2.  An FMRI study of number processing in children with fetal alcohol syndrome.

Authors:  Ernesta M Meintjes; Joseph L Jacobson; Christopher D Molteno; J Christopher Gatenby; Christopher Warton; Christopher J Cannistraci; H Eugene Hoyme; Luther K Robinson; Nathaniel Khaole; John C Gore; Sandra W Jacobson
Journal:  Alcohol Clin Exp Res       Date:  2010-06-07       Impact factor: 3.455

3.  Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn.

Authors:  Laura G Reinholdt; Yueming Ding; Griffith J Gilbert; Griffith T Gilbert; Anne Czechanski; Jeffrey P Solzak; Randall J Roper; Mark T Johnson; Leah Rae Donahue; Cathleen Lutz; Muriel T Davisson
Journal:  Mamm Genome       Date:  2011-09-28       Impact factor: 2.957

4.  Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome.

Authors:  Patrizia Bianchi; Elisabetta Ciani; Sandra Guidi; Stefania Trazzi; Daniela Felice; Gabriele Grossi; Mercedes Fernandez; Alessandro Giuliani; Laura Calzà; Renata Bartesaghi
Journal:  J Neurosci       Date:  2010-06-30       Impact factor: 6.167

Review 5.  Infections and immunodeficiency in Down syndrome.

Authors:  G Ram; J Chinen
Journal:  Clin Exp Immunol       Date:  2011-02-24       Impact factor: 4.330

6.  Verbal and nonverbal memory in adults prenatally exposed to alcohol.

Authors:  Claire D Coles; Mary Ellen Lynch; Julie A Kable; Katrina C Johnson; Felicia C Goldstein
Journal:  Alcohol Clin Exp Res       Date:  2010-03-03       Impact factor: 3.455

7.  Prenatal ethanol exposure disrupts the histological stages of fetal bone development.

Authors:  M E Snow; K Keiver
Journal:  Bone       Date:  2007-04-25       Impact factor: 4.398

Review 8.  Congenital heart defects and fetal alcohol spectrum disorders.

Authors:  Larry Burd; Eric Deal; Rodrigo Rios; Edward Adickes; Joshua Wynne; Marilyn G Klug
Journal:  Congenit Heart Dis       Date:  2007 Jul-Aug       Impact factor: 2.007

9.  Negative feedback Inhibition of NFATc1 by DYRK1A regulates bone homeostasis.

Authors:  Youngkyun Lee; Jeongim Ha; Hyung Joon Kim; Yeun-Soo Kim; Eun-Ju Chang; Woo-Joo Song; Hong-Hee Kim
Journal:  J Biol Chem       Date:  2009-10-02       Impact factor: 5.157

10.  The Down syndrome critical region protein TTC3 inhibits neuronal differentiation via RhoA and Citron kinase.

Authors:  Gaia Berto; Paola Camera; Carlo Fusco; Sara Imarisio; Chiara Ambrogio; Roberto Chiarle; Lorenzo Silengo; Ferdinando Di Cunto
Journal:  J Cell Sci       Date:  2007-05-08       Impact factor: 5.285

View more
  6 in total

1.  Ethanol Activation of PKA Mediates Single-Minded 2 Expression in Neuronal Cells.

Authors:  Xiaolan Wang; Zhihua Yang; Yinan Sun; Hanjing Zhou; Guangpin Chu; Jing Zhang; Xianfang Meng
Journal:  Mol Neurobiol       Date:  2014-10-17       Impact factor: 5.590

Review 2.  Suckling, Feeding, and Swallowing: Behaviors, Circuits, and Targets for Neurodevelopmental Pathology.

Authors:  Thomas M Maynard; Irene E Zohn; Sally A Moody; Anthony-S LaMantia
Journal:  Annu Rev Neurosci       Date:  2020-02-26       Impact factor: 12.449

3.  Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome.

Authors:  Samantha D McElyea; John M Starbuck; Danika M Tumbleson-Brink; Emily Harrington; Joshua D Blazek; Ahmed Ghoneima; Katherine Kula; Randall J Roper
Journal:  Hum Mol Genet       Date:  2016-11-15       Impact factor: 6.150

Review 4.  Connecting teratogen-induced congenital heart defects to neural crest cells and their effect on cardiac function.

Authors:  Ganga H Karunamuni; Pei Ma; Shi Gu; Andrew M Rollins; Michael W Jenkins; Michiko Watanabe
Journal:  Birth Defects Res C Embryo Today       Date:  2014-09-15

Review 5.  TTC3-Mediated Protein Quality Control, A Potential Mechanism for Cognitive Impairment.

Authors:  Xu Zhou; Xiongjin Chen; Tingting Hong; Miaoping Zhang; Yujie Cai; Lili Cui
Journal:  Cell Mol Neurobiol       Date:  2021-02-27       Impact factor: 4.231

Review 6.  Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits.

Authors:  Megan Stringer; Charles R Goodlett; Randall J Roper
Journal:  Mol Genet Genomic Med       Date:  2017-09-20       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.